Buy & Sell Viatris Inc (VTRS) – Viatris Inc Price Today
Aura AI Summary
Key Stats
- $18.07BMarket Cap
- HealthSector
- -19.65%3M Drawdown
- $31.26BEnterprise Value
- 3.09%Dividend Yield
- 55 daysTypical Hold Time
Viatris Inc (VTRS) is currently valued at a market capitalization of $18.07B, with an enterprise value of $31.26B. Over the past 52 weeks, Viatris Inc has traded between a low of $8.29 and a high of $16.13, highlighting its annual price range. Over the past three months, Viatris Inc has recorded a drawdown of -19.65%, reflecting recent price volatility. Viatris Inc offers a dividend yield of 3.09%, with the most recent dividend of $0.12 paid on 09 Mar 26. On average, investors hold Viatris Inc for approximately 55 days, indicating typical investor behavior on the platform.
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Most Recent News
Pakistan’s HBL launches Temenos Core Banking, modernizing 40M accounts across 200 branches.
Habib Bank Limited (HBL) in Pakistan has successfully implemented Temenos Core Banking, marking a major modernization effort. The initial phase migrated accounts from 200 branches, supporting both Conventional and Islamic banking. Once fully deployed...
Sadot Group stock plunges 25% after Nasdaq warns on shareholder equity shortfall
Sadot Group Inc. shares fell nearly 25% in after-hours trading after Nasdaq issued a compliance notice due to the company not meeting minimum shareholder equity requirements. The Texas-based food supply chain company reported a shareholder deficit of...
HawkEye 360 prices IPO at $26, raising $416M ahead of NYSE debut as space analytics demand grows
HawkEye 360, a space analytics company based in Virginia, set its IPO price at $26 per share, selling 16 million shares to raise approximately $416 million before fees. The company will begin trading on the New York Stock Exchange under the ticker "H...